🔴 Indaptus Therapeutics is trading 13.93% down in after-hours trading — no clear catalyst identified

Indaptus Therapeutics is trading 13.93% down at $1.05 after closing at $1.22 on September 4, 2026, with no clear catalyst identified for the after-hours decline.

• No fresh company-specific announcement, earnings release, regulatory action, or other clear catalyst was identified.
• The latest notable corporate update remains the August 13, 2026 second-quarter report and strategic update.
• Shares gained 5.17% during the regular session while major indexes declined, making the after-hours move appear unexplained rather than clearly tied to broad market sentiment.